BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20543865)

  • 21. Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-Nup358 complex.
    Reverter D; Lima CD
    Nature; 2005 Jun; 435(7042):687-92. PubMed ID: 15931224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction between a cellular protein that binds to the C-terminal region of adenovirus E1A (CtBP) and a novel cellular protein is disrupted by E1A through a conserved PLDLS motif.
    Schaeper U; Subramanian T; Lim L; Boyd JM; Chinnadurai G
    J Biol Chem; 1998 Apr; 273(15):8549-52. PubMed ID: 9535825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ubc9 sumoylation regulates SUMO target discrimination.
    Knipscheer P; Flotho A; Klug H; Olsen JV; van Dijk WJ; Fish A; Johnson ES; Mann M; Sixma TK; Pichler A
    Mol Cell; 2008 Aug; 31(3):371-82. PubMed ID: 18691969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The type 2 dengue virus envelope protein interacts with small ubiquitin-like modifier-1 (SUMO-1) conjugating enzyme 9 (Ubc9).
    Chiu MW; Shih HM; Yang TH; Yang YL
    J Biomed Sci; 2007 May; 14(3):429-44. PubMed ID: 17265167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extreme N terminus of E1A oncoprotein specifically associates with a new set of cellular proteins.
    Sang N; Giordano A
    J Cell Physiol; 1997 Feb; 170(2):182-91. PubMed ID: 9009147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Transcriptional Repressor BS69 is a Conserved Target of the E1A Proteins from Several Human Adenovirus Species.
    Zhang A; Tessier TM; Galpin KJC; King CR; Gameiro SF; Anderson WW; Yousef AF; Qin WT; Li SSC; Mymryk JS
    Viruses; 2018 Nov; 10(12):. PubMed ID: 30469473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Solution structure of human SUMO-3 C47S and its binding surface for Ubc9.
    Ding H; Xu Y; Chen Q; Dai H; Tang Y; Wu J; Shi Y
    Biochemistry; 2005 Mar; 44(8):2790-9. PubMed ID: 15723523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of two residues proximal to the active site of Ubc9 in substrate recognition by the Ubc9.SUMO-1 thiolester complex.
    Tatham MH; Chen Y; Hay RT
    Biochemistry; 2003 Mar; 42(11):3168-79. PubMed ID: 12641448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular context of coregulator and adaptor proteins regulates human adenovirus 5 early region 1A-dependent gene activation by the thyroid hormone receptor.
    Meng X; Yang YF; Cao X; Govindan MV; Shuen M; Hollenberg AN; Mymryk JS; Walfish PG
    Mol Endocrinol; 2003 Jun; 17(6):1095-105. PubMed ID: 12637585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dnmt3b, de novo DNA methyltransferase, interacts with SUMO-1 and Ubc9 through its N-terminal region and is subject to modification by SUMO-1.
    Kang ES; Park CW; Chung JH
    Biochem Biophys Res Commun; 2001 Dec; 289(4):862-8. PubMed ID: 11735126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The intracellular association of the nucleocapsid protein (NP) of hantaan virus (HTNV) with small ubiquitin-like modifier-1 (SUMO-1) conjugating enzyme 9 (Ubc9).
    Maeda A; Lee BH; Yoshimatsu K; Saijo M; Kurane I; Arikawa J; Morikawa S
    Virology; 2003 Jan; 305(2):288-97. PubMed ID: 12573574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Caspase recruitment domain of procaspase-2 could be a target for SUMO-1 modification through Ubc9.
    Shirakura H; Hayashi N; Ogino S; Tsuruma K; Uehara T; Nomura Y
    Biochem Biophys Res Commun; 2005 Jun; 331(4):1007-15. PubMed ID: 15882978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure and analysis of a complex between SUMO and Ubc9 illustrates features of a conserved E2-Ubl interaction.
    Capili AD; Lima CD
    J Mol Biol; 2007 Jun; 369(3):608-18. PubMed ID: 17466333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenovirus-5 E1A: paradox and paradigm.
    Frisch SM; Mymryk JS
    Nat Rev Mol Cell Biol; 2002 Jun; 3(6):441-52. PubMed ID: 12042766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sumoylation and proteasomal activity determine the transactivation properties of the mineralocorticoid receptor.
    Tirard M; Almeida OF; Hutzler P; Melchior F; Michaelidis TM
    Mol Cell Endocrinol; 2007 Mar; 268(1-2):20-9. PubMed ID: 17314004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SUMO-1 modification required for transformation by adenovirus type 5 early region 1B 55-kDa oncoprotein.
    Endter C; Kzhyshkowska J; Stauber R; Dobner T
    Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11312-7. PubMed ID: 11553772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ubc9 interacts with Lu/BCAM adhesion glycoproteins and regulates their stability at the membrane of polarized MDCK cells.
    Collec E; El Nemer W; Gauthier E; Gane P; Lecomte MC; Dhermy D; Cartron JP; Colin Y; Le van Kim C; Rahuel C
    Biochem J; 2007 Mar; 402(2):311-9. PubMed ID: 17087659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of papillomavirus E1 helicase mutants defective for interaction with the SUMO-conjugating enzyme Ubc9.
    Fradet-Turcotte A; Brault K; Titolo S; Howley PM; Archambault J
    Virology; 2009 Dec; 395(2):190-201. PubMed ID: 19836047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BS69, an adenovirus E1A-associated protein, inhibits the transcriptional activity of c-Myb.
    Ladendorff NE; Wu S; Lipsick JS
    Oncogene; 2001 Jan; 20(1):125-32. PubMed ID: 11244510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and characterization of multiple conserved nuclear localization signals within adenovirus E1A.
    Marshall KS; Cohen MJ; Fonseca GJ; Todorovic B; King CR; Yousef AF; Zhang Z; Mymryk JS
    Virology; 2014 Apr; 454-455():206-14. PubMed ID: 24725947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.